Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and May 2020

Filter by type
Showing 1 to 10 of 1,941
Title Reference number Published Last updated
Larotrectinib for treating NTRK fusion-positive solid tumours Reference number:TA630 TA00630 Published:27 May 2020 20200527 Last updated:27 May 2020 20200527
COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 Reference number:ES24 ES00024 Published:21 May 2020 20200521 Last updated:21 May 2020 20200521
COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 Reference number:ES25 ES00025 Published:21 May 2020 20200521 Last updated:21 May 2020 20200521
COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis Reference number:ES26 ES00026 Published:21 May 2020 20200521 Last updated:21 May 2020 20200521
Cytokine adsorption devices for treating respiratory failure in people with COVID-19 Reference number:MIB217 MIB00217 Published:21 May 2020 20200521 Last updated:21 May 2020 20200521
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer Reference number:TA628 TA00628 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab Reference number:TA629 TA00629 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
Space from Depression for treating adults with depression Reference number:MIB215 MIB00215 Published:07 May 2020 20200507 Last updated:07 May 2020 20200507
COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 Reference number:ES23 ES00023 Published:14 April 2020 20200414 Last updated:14 April 2020 20200414
Lifelight First for monitoring vital signs Reference number:MIB213 MIB00213 Published:08 April 2020 20200408 Last updated:08 April 2020 20200408